MRI boosts myocardial infarction assessment
Combining T2-weighted MRI to detect microvascular obstructions with delayed-enhancement imaging to measure tissue viability offers clinicians a better way to assess myocardial infarction, according to a new study from Japan.
Combining T2-weighted MRI to detect microvascular obstructions with delayed-enhancement imaging to measure tissue viability offers clinicians a better way to assess myocardial infarction, according to a new study from Japan.
“Non–contrast-enhanced MRI alone is not sufficient for accurate diagnosis of acute MI,” said principal investigator Dr. Yoko Mikami, a radiologist at Tsu City's Mie University Hospital.
Mikami and colleagues prospectively enrolled 37 patients diagnosed with acute myocardial infarction. Patients underwent a protocol including T2-weighted and late-enhanced MRI about five days after the onset of acute myocardial infarction. The investigators found that T2 imaging accurately pinned down areas of microvascular obstruction, which strongly correlate with post-MI hemorrhagic infarction.
The findings appeared in the October issue of the American Journal of Roentgenology.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
